DOI: https://doi.org/10.22141/2224-0551.15.1.2020.196753

Local treatment of pharyngitis in children

A.E. Abaturov, N.M. Tokarieva

Abstract


Acute respiratory diseases (ARDs) rank first in the structure of the total incidence as confirmed by the World Health Organization newsletters, and remain a serious problem for the healthcare and economy of different countries nowadays. Therefore, a rational approach to their treatment is important for each practicing pediatrician. Every 15–20 years, there are major changes in the structure of the main pathogens taking place in the etiologic structure of ARDs, which undoubtedly has a significant effect on the existing diagnostic and therapeutic measures for the treatment of ARDs. Clinical presentation of the disease of almost any etiology includes symptoms of pharyngitis and tonsillopharyngitis. The issue of effective treatment and prevention of acute respiratory viral infections is relevant worldwide due to the high prevalence, tendency to recurrent course and significant expenses on treatment. The main criterion for the choice of therapy is minimization of medical burden along with sufficient effectiveness of the treatment. Given the challenging choice of drugs prescribed as etiotropic therapy in the treatment of acute upper respiratory diseases in children, drugs having local anti-inflammatory and sanogenetic effects are of particular importance. The use of combination drugs is most expedient as they have a comprehensive (antimicrobial, anti-inflammatory and painkilling) effect at the same time. The article presents modern researches, as well as experience of practicing pediatricians on the choice of an optimal form of local antibacterial drugs for children of 6 years of age and older in the treatment of upper respiratory tract infections in pediatric patients.

Keywords


acute respiratory diseases; combined drugs; Strepsils®; tonsillopharyngitis; pharyngitis

References


Abaturov AYe, Gerasimenko ON. Features of antibacterial therapy for respiratory infections in children. Zdorovʹe rebenka. 2014;(56):61–65. doi:10.22141/2224-0551.5.56.2014.76276. (in Russian).

Antipkin YuG, Volosovets OP, Maidannik VG, et al. Children's health status – the future of the country (part 2). Zdorovʹe rebenka. 2018;13(2):142–152. doi:10.22141/2224-0551.13.2.2018.129546. (in Russian).

Antipkin YuG, Tkachenko VN. Differential diagnosis of exacerbations of chronic pharyngitis. Journal of Ear, Nose and Throat Diseases. 2011;(3):27–28. (in Russian).

Zaitseva OV. Acute rhinopharyngitis in pediatric practice. Lechaschii Vrach. 2012;(10):68. (in Russian).

Kladova OV. Local antiseptic therapy for infectious diseases of the respiratory tract in children. Praktika pediatra. 2012;(9):52–54. (in Russian).

Polunina TA, Vishneva EA. Pharyngitis in children. Pediatricheskaya Farmakologiya. 2011;8(5):106–108. (in Russian).

Riazantsev SV. Topical anti-inflammatory therapy for pharyngeal diseases. Doktor.Ru. 2010;(57):22–26. (in Russian).

Soldatskiy YuL, Onufrieva EK, Gasparyan SF, Tcshepin NV, Steklov AM. Choosing of the optimal local medicine for the treatment of pharyngitis in children. Voprosy sovremennoj pediatrii. 2012;11(2):94–97. doi:10.15690/vsp.v11i2.218. (in Russian).

Soldatskii IuL. Symptomatic treatment of infection-inflammatory pharyngeal diseases. Lechaschii Vrach. 2014;(10):7. (in Russian).

Kriuchko TA, Tkachenko OIa, Shpekht TV. The problem of tonsillitis in pediatric practice. Zdorovʹe rebenka. 2010;(22):79–82. (in Russian).

Shevchik EA, Nikiforova GN, Bidanova DB. Topical therapy of inflammatory pharyngeal diseases. Meditsinskiy sovet. 2016;(18):121–123. (in Russian).

Yulish YeI, Chernyshova OYe, Krivuschev BI, Glinskaya YeV, Levchenko AA. Pathogenetic therapy for inflammatory diseases of the throat in children. Zdorovʹe rebenka. 2013;(44):97–101. doi:10.22141/2224-0551.1.44.2013.86548. (in Russian).

Barbieri E, Donà D, Cantarutti A, et al. Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric outpatients. Ital J Pediatr. 2019;45(1):103. doi:10.1186/s13052-019-0696-9.

Berry P. Rapid relief of acute sore throat with Strepsils lozenges: a single-blind, comparative study. In: Oxford JS, editor. Developments in acute sore throat relief – efficacy and sensorial benefits of medicated lozenges. London: Royal Society of Medicine Press Ltd; 2008. 44 p.

Foadi N, de Oliveira RC, Buchholz V, et al. A combination of topical antiseptics for the treatment of sore throat blocks voltage-gated neuronal sodium channels. Naunyn Schmiedebergs Arch Pharmacol. 2014;387(10):991–1000. doi:10.1007/s00210-014-1016-y.

Kalra MG, Higgins KE, Perez ED. Common Questions About Streptococcal Pharyngitis. Am Fam Physician. 2016;94(1):24–31.

Marazzi PJ. Strepsils anaesthetic lozenges versus control Strepsils lozenges in the relief of moderate-to-severe sore throat: a double-blind, crossover, multiple-dose, randomized study. In: Oxford JS, editor. Developments in acute sore throat relief – efficacy and sensorial benefits of medicated lozenges. London: Royal Society of Medicine Press Ltd; 2008. 44 p.

Matthews D, Atkinson R, Shephard A. Spectrum of bactericidal action of amylmetacresol/2,4-dichlorobenzyl alcohol lozenges against oropharyngeal organisms implicated in pharyngitis. Int J Gen Med. 2018;11:451–456. doi:10.2147/IJGM.S184406.

McNally D, Simpson M, Morris C, Shephard A, Goulder M. Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial. Int J Clin Pract. 2010;64(2):194–207. doi:10.1111/j.1742-1241.2009.02230.x.

Morokutti-Kurz M, Graf C, Prieschl-Grassauer E. Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat. Int J Gen Med. 2017;10:53–60. doi:10.2147/IJGM.S120665.

Oxford JS, Lambkin R, Gibb I, Balasingam S, Chan C, Catchpole A. A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV. Antivir Chem Chemother. 2005;16(2):129–134. doi:10.1177/095632020501600205.

Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr. 2011;37:10. doi:10.1186/1824-7288-37-10.

Shephard A, Zybeshari S. Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus. Antiviral Res. 2015;123:158–162. doi:10.1016/j.antiviral.2015.09.012.

Tan TW, Chen BC, Tan HL, Chang CM. Effectiveness of amylmetacresol and 2,4-dichlorobenzyl alcohol throat lozenges in patients with acute sore throat due to upper respiratory tract infection: a systematic review protocol. JBI Database System Rev Implement Rep. 2017;15(4):862–872. doi:10.11124/JBISRIR-2016-003034.

Vazquez MN, Sanders JE. Diagnosis and management of group A streptococcal pharyngitis and associated complications. Pediatr Emerg Med Pract. 2017;14(12):1–20.

Wade AG, Morris C, Shephard A, Crawford GM, Goulder MA. A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat. BMC Fam Pract. 2011;12:6. doi:10.1186/1471-2296-12-6.

Wade AG. A randomised, double-blind, parallel-group, placebo-controlled, multiple-dose study of the efficacy of Strepsils lozenges in the relief of acute sore throat. In: Oxford JS, editor. Developments in acute sore throat relief – efficacy and sensorial benefits of medicated lozenges. London: Royal Society of Medicine Press Ltd; 2008. 44 p.

Weber R. Pharyngitis. Prim Care. 2014;41(1):91–98. doi:10.1016/j.pop.2013.10.010.

Weckmann G, Hauptmann-Voß A, Baumeister SE, Klötzer C, Chenot JF. Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis. Int J Clin Pract. 2017;71(10):10.1111/ijcp.13002. doi:10.1111/ijcp.13002.

Wessels MR. Clinical practice. Streptococcal pharyngitis. N Engl J Med. 2011;364(7):648–655. doi:10.1056/NEJMcp1009126.

Williamson DA, Carter GP, Howden BP. Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns. Clin Microbiol Rev. 2017;30(3):827–860. doi:10.1128/CMR.00112-16.






Copyright (c) 2020 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2020

 

   Seo анализ сайта